Case Study: Uncovering Potential for Products with Clinical, Epidemiology, and Real-World Cost Benefits
The ADVI Market Access team assisted a client in uncovering opportunities for their product to truly make a difference in patient lives beyond just clinical potential. Hear more from Yana Volman, market access – pharma solution leader, as she shares insights from this successful partnership.
Video Transcript
Melyssa: I’m hoping we can have a little fun with this “2023 at a glance” question, especially with the mention of Twitter – or X for that matter. Is it still called a Tweet? As a live X, in 280 characters, or less describe a project you engaged in this year that yielded results that you’re proud of.
Yana: There are so many examples to choose from, but we just completed a market effort in cell therapy that has a lot of promise in the complexity state. We considered its clinical potential, but also epidemiology and real-world cost to define a patient population where their product can truly make a difference.
Learn More
Stay ahead of the curve. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.
CEO insights
Related articles
Real analysis from people who’ve been there
CMMI Engagement on CGT Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.